CHINA PHARMA HOLDINGS, INC. (CPHI)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 500K 1M 1.5M Q3 '24: 1.1M Q4 '24: 1.1M Q1 '25: 1.1M Q2 '25: 1M Q3 '25: 756.2K Q4 '25: 1.2M Q1 '26: 983.5K Q2 '26: 948.3K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

-600K -400K -200K 0 200K 400K 600K Q3 '24: -519.6K Q4 '24: -160.6K Q1 '25: -136.1K Q2 '25: -87K Q3 '25: -59.7K Q4 '25: 150.8K Q1 '26: 285.5K Q2 '26: 83.6K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Income Quarterly

-1.5M -1M -500K 0 500K 1M 1.5M Q3 '24: -1.1M Q4 '24: -1.2M Q1 '25: -758.6K Q2 '25: -652.1K Q3 '25: -628.1K Q4 '25: -1.2M Q1 '26: -1.1M Q2 '26: -1.4M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-1.5M -1M -500K 0 500K 1M 1.5M Q3 '24: -1.1M Q4 '24: -1.2M Q1 '25: -785.6K Q2 '25: -528.4K Q3 '25: -651.5K Q4 '25: -1.2M Q1 '26: -1.1M Q2 '26: -1.5M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 600K 1.2M 1.8M Q3 '24: 1.6M Q4 '24: 1.3M Q1 '25: 1.3M Q2 '25: 1.1M Q3 '25: 815.9K Q4 '25: 1.1M Q1 '26: 698K Q2 '26: 864.8K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

-300K -200K -100K 0 100K 200K 300K Q2 '24: -72.7K Q3 '24: -47K Q1 '25: -73.7K Q2 '25: 274.3K Q3 '25: -204.4K Q4 '25: 152K Q1 '26: -55.3K Q2 '26: -32.8K Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-900K -600K -300K 0 300K 600K 900K Q1 '22: -880.8K Q2 '22: -509.1K Q3 '22: -33.4K Q3 '24: -56.2K Q1 '25: -132K Q2 '25: 274.2K Q3 '25: -205K Q4 '25: 151.5K Q1 '22 Q2 '22 Q3 '22 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q1 '24: 1.3M Q2 '24: 1.6M Q3 '24: 1.7M Q1 '25: 3.3M Q2 '25: 3.2M Q3 '25: 3.9M Q1 '26: 25.6M Q2 '26: 40.5M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-3.00 -2.00 -1.00 0.00 1.00 2.00 3.00 Q3 '24: -2.28 Q4 '24: -2.72 Q1 '25: -2.24 Q2 '25: -1.51 Q3 '25: -1.03 Q4 '25: -0.74 Q1 '26: -0.54 Q2 '26: -0.42 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.